Preparing for the Era of Multiple Primary Cancers: A Prevention-Centered Model for Survivorship Medicine.

IF 2.7 4区 医学 Q3 ONCOLOGY
Technology in Cancer Research & Treatment Pub Date : 2026-01-01 Epub Date: 2026-09-09 DOI:10.1177/15330338261488983
Tessho Maruyama
{"title":"Preparing for the Era of Multiple Primary Cancers: A Prevention-Centered Model for Survivorship Medicine.","authors":"Tessho Maruyama","doi":"10.1177/15330338261488983","DOIUrl":null,"url":null,"abstract":"<p><p>The number of cancer survivors is increasing rapidly, and the development of multiple primary cancers (MPCs) is becoming a foreseeable consequence of long-term survival. However, MPC detection remains fragmented. Clinical information is often scattered across institutions, and long-term follow-up is not always consistent. Early warning signs that appear outside oncology settings are also not always linked to a patient's prior cancer history. As the number of cancer survivors increases, these gaps can have important clinical consequences. This Perspective presents a prevention-centered framework that complements existing survivorship care by recognizing the development of MPCs as an expected event during long-term survivorship. I outline a framework integrating longitudinal genetic and multi-omics risk stratification with artificial intelligence-assisted risk modeling and interoperable health records for continuous monitoring. Extending surveillance beyond oncology clinics to settings such as emergency medicine, primary care, and dentistry, may help detect secondary malignancies earlier. Survivorship medicine should shift from episodic detection to more coordinated, lifelong prevention. Further studies are needed to evaluate this framework across diverse healthcare settings and to determine its potential to improve earlier detection and long-term outcomes for cancer survivors.</p>","PeriodicalId":22203,"journal":{"name":"Technology in Cancer Research & Treatment","volume":"25 ","pages":"15330338261488983"},"PeriodicalIF":2.7000,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13558918/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Technology in Cancer Research & Treatment","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/15330338261488983","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/9/9 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

The number of cancer survivors is increasing rapidly, and the development of multiple primary cancers (MPCs) is becoming a foreseeable consequence of long-term survival. However, MPC detection remains fragmented. Clinical information is often scattered across institutions, and long-term follow-up is not always consistent. Early warning signs that appear outside oncology settings are also not always linked to a patient's prior cancer history. As the number of cancer survivors increases, these gaps can have important clinical consequences. This Perspective presents a prevention-centered framework that complements existing survivorship care by recognizing the development of MPCs as an expected event during long-term survivorship. I outline a framework integrating longitudinal genetic and multi-omics risk stratification with artificial intelligence-assisted risk modeling and interoperable health records for continuous monitoring. Extending surveillance beyond oncology clinics to settings such as emergency medicine, primary care, and dentistry, may help detect secondary malignancies earlier. Survivorship medicine should shift from episodic detection to more coordinated, lifelong prevention. Further studies are needed to evaluate this framework across diverse healthcare settings and to determine its potential to improve earlier detection and long-term outcomes for cancer survivors.

为多原发癌症时代做准备:以预防为中心的生存医学模式。
癌症幸存者的数量正在迅速增加,多原发癌症(MPCs)的发展正在成为长期生存的可预见的后果。然而,MPC检测仍然是碎片化的。临床信息往往分散在各个机构,长期随访并不总是一致的。在肿瘤学之外出现的早期预警信号也并不总是与患者以前的癌症病史有关。随着癌症幸存者人数的增加,这些差距可能会产生重要的临床后果。本观点提出了一个以预防为中心的框架,通过认识到MPCs的发展是长期生存期间的预期事件,补充了现有的生存护理。我概述了一个框架,将纵向遗传和多组学风险分层与人工智能辅助的风险建模和可互操作的健康记录相结合,以进行持续监测。将监测从肿瘤诊所扩展到急诊医学、初级保健和牙科等环境,可能有助于更早地发现继发性恶性肿瘤。生存医学应该从偶发检测转向更协调的终身预防。需要进一步的研究在不同的医疗环境中评估这一框架,并确定其改善癌症幸存者早期检测和长期预后的潜力。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
4.40
自引率
0.00%
发文量
202
审稿时长
2 months
期刊介绍: Technology in Cancer Research & Treatment (TCRT) is a JCR-ranked, broad-spectrum, open access, peer-reviewed publication whose aim is to provide researchers and clinicians with a platform to share and discuss developments in the prevention, diagnosis, treatment, and monitoring of cancer.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书